In addition, oncolytic attenuated measles virus encoding single-chain variable regions of CTLA-4 and PD-L1 antibodies have been shown to delay tumor progression and increase survival in an immunocompetent syngeneic mouse model of melanoma [69]. Here, CTLA4 is linked to melanoma.